Asian Pacific Journal of Tropical Medicine

LETTER TO EDITOR
Year
: 2021  |  Volume : 14  |  Issue : 1  |  Page : 47--48

Association between Guillain-Barré syndrome and hepatitis E infection: A data-driven ecological study in Hong Kong


Xue Liang1, Shi Zhao2,  
1 Department of Hematology, The 989th Hospital of the Joint Logistics Support Force of Chinese PLA, Luoyang, 471031, China
2 JC School of Public Health and Primary Care, Chinese University of Hong Kong, Hong Kong SAR; Shenzhen Research Institute of Chinese University of Hong Kong, Shenzhen, China

Correspondence Address:
Shi Zhao
JC School of Public Health and Primary Care, Chinese University of Hong Kong, Hong Kong SAR; Shenzhen Research Institute of Chinese University of Hong Kong, Shenzhen
China




How to cite this article:
Liang X, Zhao S. Association between Guillain-Barré syndrome and hepatitis E infection: A data-driven ecological study in Hong Kong.Asian Pac J Trop Med 2021;14:47-48


How to cite this URL:
Liang X, Zhao S. Association between Guillain-Barré syndrome and hepatitis E infection: A data-driven ecological study in Hong Kong. Asian Pac J Trop Med [serial online] 2021 [cited 2021 Feb 25 ];14:47-48
Available from: https://www.apjtm.org/text.asp?2021/14/1/47/304301


Full Text

Guillain-Barré syndrome (GBS) is an uncommon neurological disorder that may cause damage to the peripheral nerves[1]. The triggering of GBS is commonly caused by Campylobacter jejuni and other bacterial and viral infections. Hepatitis infections as the triggering factors including hepatitis A, B, C, E viruses are being increasingly recognized[2],[3]. Among all hepatitis, hepatitis E virus (HEV) is more likely to be under-diagnosed, most being subclinical infections. In developed countries, extra-hepatic manifestations as well as clinical disorders may occur[2].

In Hong Kong, there are 0.79 GBS per 100 000 population every year from 2004 to 2018 with an annual growth of 1.91%. Although recently, many studies have suggested an association between GBS and some flavivirus, e.g., Zika virus, dengue virus[4],[5], and Chikungunya virus. The number of the local infections of these viruses is at extremely low levels, some with an annual number of zero cases[6]. For hepatitis, there are 3.30 hepatitis cases per 100 000 population every year of the same period including 1.13 HEV cases[6]. To the best of our knowledge, only one case report on GBS associated with HEV was published in the preceding 20 years[7].

As an exploration, we investigated the statistical associations between GBS and hepatotropic viruses in Hong Kong from 2004 to 2018. The monthly number of GBS and different types of hepatitis time series was freely obtained via the Centre for Health Protection (CHP) of Hong Kong[6]. Linear fixed effect regression was employed to model the number of GBS as a response to different types of hepatitis in Eqn (1).

E[log (GBSt + τ)|I(t > 2010)]= β0+β×hepatitist (1)

Here, the function E[·] is the expectation. The term τ is the time lag, and we consider +1 month lag in GBS to account for the development of syndromes[8]. The function I(·) is an indication function, and it returns 1 for ‘true’ values, and 0 otherwise. The time period, denoted by t, before or after 2010 was considered as a dummy variable accounting for unexplainable variation before and after influenza pandemic. As such, the regression coefficient, β, can be transferred to ‘percentage change of GBS when one unit increases in hepatitis’, namely, [(eβ-1)×100%] is the percentage change.

We found a positive association between GBS and HEV that can be interpreted as an estimated 2.01% (95% CI: 0.41%-3.62%) increase in the number of GBS about to occur if there is an increase of one more HEV case. This estimation became 2.61% (95% CI: 1.01%-4.24%) when only data after 2010 was used [Figure 1]. This association did not reach significance in 2004 to 2009, and all other hepatotropic viruses were not significantly associated with GBS, either. The under-diagnosis of HEV infection may cause extra occurrences of manifestations of the disorder[2], which includes GBS as one of the commonly noticed complications. Our findings suggest that extra caution may be needed for the situation that HEV is complicated by GBS.{Figure 1}

Conflict of interest statement

The authors declare that there are no conflicts of interests.

Authors’ contributions

All authors designed the study, collected the data, conducted the analysis, drafted and critically revised the manuscript, and approved for publishing.

References

1Zambrano LI, Fuentes-Barahona IC, Soto-Fernández RJ, Zuniga C, da Silva JC, Rodriguez-Morales AJ. Guillain-Barré syndrome associated with Zika virus infection in Honduras, 2016-2017. Int J Infect Dis 2019; 84:136-137.
2Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: An emerging infection in developed countries. Lancet Infect Dis 2008; 8(11): 698-709.
3Cheung MC, Maguire J, Carey I, Wendon J, Agarwal K. Review of the neurological manifestations of hepatitis E infection. Ann Hepatol 2012; 11(5): 618-622.
4dos Santos T, Rodriguez A, Almiron M, Sanhueza A, Ramon P, de Oliveira WK, et al. Zika virus and the Guillain-Barré syndrome: Case series from seven countries. N Engl J Med 2016; 375(16): 1598-1601.
5Tang X, Zhao S, Chiu AP, Wang X, Yang L, He D. Analysing increasing trends of Guillain-Barré Syndrome (GBS) and dengue cases in Hong Kong using meteorological data. PLoS One 2017; 12(12): e0187830.
6Centre for Health Protection. Number of notifiable infectious diseases monthly report, Centre for Health Protection, the Government of the Hong Kong. 2019. [Online]. Available from: https://www.chp.gov.hk/en/ static/24012.html. [Accessed on 23 September 2020].
7Alan C, Cheung RT, Ho SL, Chan KH. Guillain-Barré syndrome associated with acute hepatitis E infection. J Clin Neurosci 2012; 19(4): 607-608.
8National Institutes of Health (NIH). The Guillain-Barré syndrome fact sheet, the official website of the National Institute of Neurological Disorders and Stroke, the National Institutes of Health (NIH) of the United States of America. 2019. [Online]. Available from: https://www.ninds. nih.gov/Disorders/Patient-Caregiver-Education/Fact-sheets/Guillain-Barr%C3%A9-Syndrome-Fact-Sheet.[Accessed on 23 September 2020].